Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOS-589 in IBS-D
NCT03977155Phase 2Completed
- Sponsor
- Boston Pharmaceuticals
- Start
- Jun 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BOS-589 in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Boston Pharmaceuticals. Started Jun 2019; status: completed.
02
Drugs
BOS-589
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT03977155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03977155.